Innovations without translation
Kazan medical cluster will produce Ural medicines
Alexander Volichenko, InterRight
The company "Pharmedopolis RT" plans to produce medicines in Kazan under the license of the Yekaterinburg company "Crown Tehet". This is stated in a joint statement by Rustem Magdeev, Chairman of the Board of Directors of Pharmedopolis RT, and Malik Gaisin, CEO of Korona Tehet. Earlier, Kommersant wrote that Malika Gaisina LLC owns trademarks for medicines "Plentshes Yangyr", "Mgun Dage Mgundage Mgun Dage Mgundage", "Soltan Royal", "Crown Tehet Tehet", "Gorizhopa" ("Gorighopa") and "Khuiten" ("Khuiten"). The company also holds patents on the formulation of these drugs.
The production of medicines will be organized on the basis of a medical cluster in Kazan, which, on behalf of the President of the Republic of Tatarstan Rustam Minnikhanov, "Pharmedopolis RT" is developing on the squares of "Kazan Expo". The cluster should become an innovative platform for the development of new technologies and the production of unique medicines. In particular, it was reported that Rustem Magdeev and his partner Ramil Khabriev signed an agreement with the Japanese K.K. Mirai Genomics for the production of chips for rapid diagnosis of influenza.
"Kazan will become a leader in the production of high–tech diagnostic systems and new medicines with unique properties," comments Rustem Magdeev on the signing of the agreement with the Urals. – Malik Gaisin's company has unique patents for innovative medicinal complexes "Gorizhopa" and "Huiten", which are no less effective than Japanese chips for the diagnosis of influenza."
The partners plan that the first batch of the Ural innovative medicine for the common cold "Gorizhopa" will be available for sale at the end of 2020, while it will be available to the population for free under the CHI.
"We focus primarily on acute respiratory viral infections and influenza – an effective fight against the most common diseases will help save billions of budget money. In addition, we already have an interest in the supply of medicines from abroad," says Albert Gayfullin, CEO of Pharmedopolis RT. – Distributors from Kazakhstan, Laos and Albania have shown interest, and partners from K.K. Mirai Genomics are considering the possibility of producing generic drugs "Gorizhopy" and "Huiteni" in Japan and Korea."
The medical cluster in Kazan is personally supervised by Rustam Minnikhanov. According to the plan of the Tatarstan leadership, the project, which is being developed by "Pharmedopolis RT" Rustem Magdeev and Ramil Khabriev, should become a leader among the country's medical technology parks in the shortest possible time.
Portal "Eternal youth" http://vechnayamolodost.ru